Test Background
SNP Therapeutics has a U.S. PATENT on a Genetic Test, Algorithm and Nutrition Treatment for ATP-Sperm Function. This Genetic test identifies a sub-population of men who are at high risk for ATP-Sperm Dysfunction due to variant genes in metabolic pathways associated with spermatic ATP (function)concentrations. Men with this SNP pattern can be treated with a patented nutritional formulation.
-
![Gene Guided Nutri Icon]()
Male Factor Infertility
It is estimated that 15% of couples worldwide have infertility issues and that 50% of infertility in couples worldwide is due to male factor issues.
-
![Gene Guided Nutri Icon]()
Prevalence
Large worldwide market opportunity. There is an estimated 28 million infertile men in North America and Europe
-
![Gene Guided Nutri Icon]()
Nutritional Intervention Provides Value to Couples Desperate to Conceive
Genetic Testing can help many couples prior to making significant investment in In Vitro Fertilization
